Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2000;59(Supplement 1 ):i75-i80; doi:10.1136/ard.59.suppl_1.i75
Copyright © 2000 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2000;59(Suppl 1):i75-i80 ( November )

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha

Richard O Williams, Marc Feldmann, Ravinder N Maini

Kennedy Institute of Rheumatology, 1 Aspenlea Road, London W6 8LH

Correspondence to: Dr Williams (r.williams@cxwms.ac.uk)

The first 150 words of the full text of this article appear below.

    Introduction

Rheumatoid arthritis (RA) is a chronic disabling disease characterised by synovitis, destruction of cartilage and bone and, ultimately, loss of joint function. A great deal of research in rheumatology over the past two decades has focused on identifying cytokines and other mediators responsible for the inflammatory and degenerative processes in RA, with the aim of developing specific inhibitors or antagonists of therapeutic value. A key question in this research has been whether there is a degree of hierarchy in proinflammatory cytokine expression in RA, such that inhibiting the activity of a cytokine high up in the inflammatory cascade has an impact on the expression of downstream mediators of inflammation and joint damage.

Of the many cytokines thought to contribute to the inflammatory and degenerative changes that occur in RA, tumour necrosis factor alpha  (TNFalpha ) has emerged as being of major pathological significance. For example, TNFalpha was identified in the synovial . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Roy, C. N., Mak, H. H., Akpan, I., Losyev, G., Zurakowski, D., Andrews, N. C. (2007). Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109: 4038-4044 [Abstract] [Full Text]  
  • Ostensen, M, Forger, F, Nelson, J L, Schuhmacher, A, Hebisch, G, Villiger, P M (2005). Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64: 839-844 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs